메뉴 건너뛰기




Volumn 16, Issue 20, 2008, Pages 9217-9229

Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis

Author keywords

Bisphosphonates; Drug delivery; Fluoroquinolone; Osteomyelitis; Prodrug

Indexed keywords

1,1 BISPHOSPHONOMETHYLCARBAMOYL)METHYL 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 7 (OCTAHYDROPYRROLO[3,4 B]PYRIDIN 6 YL) 8 METHOXY 4 OXOQUINOLINE 3 CARBOXYLATE; 1,1 BISPHOSPHONOMETHYLCARBAMOYL)METHYL 7 (3 METHYLPIPERAZIN 1 YL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 8 METHOXY 4 OXOQUINOLINE 3 CARBOXYLATE; BISPHOSPHONIC ACID DERIVATIVE; CIPROFLOXACIN; GATIFLOXACIN; MOXIFLOXACIN; PRODRUG; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 53249107123     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.09.010     Document Type: Article
Times cited : (41)

References (40)
  • 39
    • 53249131111 scopus 로고    scopus 로고
    • note
    • [CLSI] Clinical and Laboratory Standards Institute. 2006a. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Seventh Edition. CLSI document M7-A7 (ISBN 1-56238-587-9). Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.